Get it on Google Play

Cuprina gets FDA clearance for first Lucilia cuprina maggot therapy

June 15, 2026 9:00 AM EDT Send to a Friend
Cuprina Holdings (NASDAQ: CUPR) received U.S. Food and Drug Administration 510(k) clearance for MEDIFLY Maggots, a medical-grade Lucilia cuprina larvae ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login